Pharmaceutical compositions for the treatment or prevention of d

Details Pharmaceutical compositions for the treatment or prevention of d Pharmaceutical compositions for the treatment or prevention of d

1995-12-12

1999-03-02

Tsang, Cecilia J.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

530517, A61K 3800

Patent

active

058771549

ABSTRACT:
Eye diseases or disorders are treated by an active agent being a melanotropin peptide or an analogue thereof, the analogue being an agent having a biological effect resembling that of the melanotropin peptide. The active agent may be administered topically onto the eye, by injection into the eye or systemically.

REFERENCES:
T. Hanaoka, "Effect of Melanophore Hormone on Regeneration of Visual Purple in Solution", Nature, vol. 172, 1953, p. 866.
O.G. Stroeva et al., "A Hormone-Sensitive Stage in Development of the Retinal Pigment Epithelium in the Hunter Rats with Inherited Retinal Distrophy", Ontogenez, vol. 19, No. 1, 1988, pp. 30-36.
Benelli, et al, Europ. Journal of Pharmacology, 150 211-219, 1988.
Hiltz, et al, Peptides, vol. 12, pp. 769-771, 1991.
Eberle, A.N., Karger Press, 1988, pp. 336-337, 346-349, 459-461.

Affiliated with

Also associated with

Rating

Pharmaceutical compositions for the treatment or prevention of d does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical compositions for the treatment or prevention of d, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical compositions for the treatment or prevention of d will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-422946